Inhibitors of topoisomerase II: Structure-activity relationships and mechanism of action of podophyllin congeners
- 31 December 1988
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 27, 211-214
- https://doi.org/10.1016/0065-2571(88)90019-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyPharmacology & Therapeutics, 1987
- Intercalator-induced, toposiomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolitesInternational Journal of Radiation Oncology*Biology*Physics, 1986
- DNA topoisomerases as targets for cancer therapyBiochemical Pharmacology, 1985
- DNA topoisomerase II is required at the time of mitosis in yeastCell, 1985
- Localization of topoisomerase II in mitotic chromosomes.The Journal of cell biology, 1985
- Topoisomerase II is a structural component of mitotic chromosome scaffolds.The Journal of cell biology, 1985
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984
- Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26Biochemical and Biophysical Research Communications, 1984
- Chromatin assembly in Xenopus oocytes: In vivo studiesCell, 1984
- Evidence that mAMSA induces topoisomerase actionFEBS Letters, 1983